Experts warn that loss of carcinogen surveillance threatens to increase cancer incidence

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Testing of chemicals for potential cancer causation (carcinogenesis) has long been a successful disease-prevention initiative of the highest priority. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
David M. DeMarini, PhD
Former research biologist, Office of Research and Development, U.S. Environmental Protection Agency  
Rosalie Elespuru, PhD
Former researcher and reviewer, Center for Devices and Radiological Health, U.S. Food and Drug Administration
Miriam C. Poirier, PhD
Scientist emeritus, Former chief, Carcinogen-DNA Interactions Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Errol Zeiger, PhD, JD
Principal, Errol Zeiger Consulting; Former toxicologist, National Institute of Environmental Health Sciences, National Institutes of Health
Table of Contents

YOU MAY BE INTERESTED IN

David M. DeMarini, PhD
Former research biologist, Office of Research and Development, U.S. Environmental Protection Agency  
Rosalie Elespuru, PhD
Former researcher and reviewer, Center for Devices and Radiological Health, U.S. Food and Drug Administration
Miriam C. Poirier, PhD
Scientist emeritus, Former chief, Carcinogen-DNA Interactions Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Errol Zeiger, PhD, JD
Principal, Errol Zeiger Consulting; Former toxicologist, National Institute of Environmental Health Sciences, National Institutes of Health

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login